发明名称 Anti-TNF antibodies, compositions, methods and uses
摘要 The present invention relates to anti-TNF antibodies comprising all of the heavy chain variable CDR regions of SEQ ID NOS: 1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein or fragment thereof, as well as nucleic acids encoding such anti-TNF antibodies, complementary nucleic acids, vectors, host cells, production methods and therapeutic methods.
申请公布号 US9321836(B2) 申请公布日期 2016.04.26
申请号 US201414068010 申请日期 2014.02.18
申请人 Janssen Biotech, Inc. 发明人 Heavner George;Knight David M.;Giles-Komar Jill;Scallon Bernard;Shealy David
分类号 A61K39/395;A61K38/18;A61K38/19;A61K38/27;A61K45/06;C07K16/24;G01N33/53;C07K16/42;G01N33/566;A61K39/00 主分类号 A61K39/395
代理机构 代理人 Carey Brian C.
主权项 1. A method for treating a TNF mediated condition, comprising (a) contacting a sample from a subject with an isolated anti-TNF antibody having a variable region comprising SEQ ID NO:7 or 8; (b) detecting whether TNF is present in said sample; and, if so, (c) administering an effective amount of an isolated anti-TNF antibody having a variable region comprising SEQ ID NO:7 or 8.
地址 Horsham PA US